HatamiP, AryanianZ, Nicknam AslH, et al.Mucocutaneous adverse effects following COVID-19 vaccination: a comprehensive review of the literature with a presentation of some cases from Iran. Iran J Dermatol, 2021; 24(4):331–338. doi: 10.22034/IJD.2021.311094.1451.
2.
PigliacelliF, PacificoA, MarianoM, et al.Morphea induced by SARS-CoV-2 infection: a case report. Int J Dermatol, 2022; 61(3):377–378.
3.
SeverinoP. Morphea (Localized Scleroderma) in a COVID-19 patient: a case report. J Clin Immunol Microbiol, 2021; 2(1):1–4.
4.
FettN, WerthVP. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol, 2011; 64(2):217–228.
5.
FettN, WerthVP. Update on morphea: part II. Outcome measures and treatment. J Am Acad Dermatol, 2011; 64(2):231–242.
